Report Detail
Global Drug of Abuse Screening Market Growth (Status and Outlook) 2022-2028
- RnM4489199 |
- 01 September, 2022 |
- Global |
- 86 Pages |
- LPI(LP Information) |
- Other
The global market for Drug of Abuse Screening is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug of Abuse Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug of Abuse Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug of Abuse Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug of Abuse Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug of Abuse Screening players cover Abbott Laboratories, Inc., Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Psychemedics Corporation and Sonic Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug of Abuse Screening market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug of Abuse Screening market, with both quantitative and qualitative data, to help readers understand how the Drug of Abuse Screening market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug of Abuse Screening market and forecasts the market size by Type (On-Site Screening and Laboratory-Based Screening,), by Application (Medical and Research.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
On-Site Screening
Laboratory-Based Screening
Segmentation by application
Medical
Research
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Laboratories, Inc.
Thermo Fisher Scientific
LabCorp (Laboratory Corporation of America)
Psychemedics Corporation
Sonic Healthcare
Bio-Rad Laboratories
Quest Diagnostics
Randox Laboratories
F. Hoffman-La Roche
Chapter Introduction
Chapter 1: Scope of Drug of Abuse Screening, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug of Abuse Screening market size and CAGR, Drug of Abuse Screening market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug of Abuse Screening revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug of Abuse Screening revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug of Abuse Screening market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, Inc., Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Psychemedics Corporation, Sonic Healthcare, Bio-Rad Laboratories, Quest Diagnostics, Randox Laboratories and F. Hoffman-La Roche, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drug of Abuse Screening Market Size 2017-2028
- 2.1.2 Drug of Abuse Screening Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Drug of Abuse Screening Segment by Type
- 2.2.1 On-Site Screening
- 2.2.2 Laboratory-Based Screening
- 2.3 Drug of Abuse Screening Market Size by Type
- 2.3.1 Drug of Abuse Screening Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Drug of Abuse Screening Market Size Market Share by Type (2017-2022)
- 2.4 Drug of Abuse Screening Segment by Application
- 2.4.1 Medical
- 2.4.2 Research
- 2.5 Drug of Abuse Screening Market Size by Application
- 2.5.1 Drug of Abuse Screening Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Drug of Abuse Screening Market Size Market Share by Application (2017-2022)
3 Drug of Abuse Screening Market Size by Player
- 3.1 Drug of Abuse Screening Market Size Market Share by Players
- 3.1.1 Global Drug of Abuse Screening Revenue by Players (2020-2022)
- 3.1.2 Global Drug of Abuse Screening Revenue Market Share by Players (2020-2022)
- 3.2 Global Drug of Abuse Screening Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Drug of Abuse Screening by Regions
- 4.1 Drug of Abuse Screening Market Size by Regions (2017-2022)
- 4.2 Americas Drug of Abuse Screening Market Size Growth (2017-2022)
- 4.3 APAC Drug of Abuse Screening Market Size Growth (2017-2022)
- 4.4 Europe Drug of Abuse Screening Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Drug of Abuse Screening Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Drug of Abuse Screening Market Size by Country (2017-2022)
- 5.2 Americas Drug of Abuse Screening Market Size by Type (2017-2022)
- 5.3 Americas Drug of Abuse Screening Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Drug of Abuse Screening Market Size by Region (2017-2022)
- 6.2 APAC Drug of Abuse Screening Market Size by Type (2017-2022)
- 6.3 APAC Drug of Abuse Screening Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Drug of Abuse Screening by Country (2017-2022)
- 7.2 Europe Drug of Abuse Screening Market Size by Type (2017-2022)
- 7.3 Europe Drug of Abuse Screening Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Drug of Abuse Screening by Region (2017-2022)
- 8.2 Middle East & Africa Drug of Abuse Screening Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Drug of Abuse Screening Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Drug of Abuse Screening Market Forecast
- 10.1 Global Drug of Abuse Screening Forecast by Regions (2023-2028)
- 10.1.1 Global Drug of Abuse Screening Forecast by Regions (2023-2028)
- 10.1.2 Americas Drug of Abuse Screening Forecast
- 10.1.3 APAC Drug of Abuse Screening Forecast
- 10.1.4 Europe Drug of Abuse Screening Forecast
- 10.1.5 Middle East & Africa Drug of Abuse Screening Forecast
- 10.2 Americas Drug of Abuse Screening Forecast by Country (2023-2028)
- 10.2.1 United States Drug of Abuse Screening Market Forecast
- 10.2.2 Canada Drug of Abuse Screening Market Forecast
- 10.2.3 Mexico Drug of Abuse Screening Market Forecast
- 10.2.4 Brazil Drug of Abuse Screening Market Forecast
- 10.3 APAC Drug of Abuse Screening Forecast by Region (2023-2028)
- 10.3.1 China Drug of Abuse Screening Market Forecast
- 10.3.2 Japan Drug of Abuse Screening Market Forecast
- 10.3.3 Korea Drug of Abuse Screening Market Forecast
- 10.3.4 Southeast Asia Drug of Abuse Screening Market Forecast
- 10.3.5 India Drug of Abuse Screening Market Forecast
- 10.3.6 Australia Drug of Abuse Screening Market Forecast
- 10.4 Europe Drug of Abuse Screening Forecast by Country (2023-2028)
- 10.4.1 Germany Drug of Abuse Screening Market Forecast
- 10.4.2 France Drug of Abuse Screening Market Forecast
- 10.4.3 UK Drug of Abuse Screening Market Forecast
- 10.4.4 Italy Drug of Abuse Screening Market Forecast
- 10.4.5 Russia Drug of Abuse Screening Market Forecast
- 10.5 Middle East & Africa Drug of Abuse Screening Forecast by Region (2023-2028)
- 10.5.1 Egypt Drug of Abuse Screening Market Forecast
- 10.5.2 South Africa Drug of Abuse Screening Market Forecast
- 10.5.3 Israel Drug of Abuse Screening Market Forecast
- 10.5.4 Turkey Drug of Abuse Screening Market Forecast
- 10.5.5 GCC Countries Drug of Abuse Screening Market Forecast
- 10.6 Global Drug of Abuse Screening Forecast by Type (2023-2028)
- 10.7 Global Drug of Abuse Screening Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Abbott Laboratories, Inc.
- 11.1.1 Abbott Laboratories, Inc. Company Information
- 11.1.2 Abbott Laboratories, Inc. Drug of Abuse Screening Product Offered
- 11.1.3 Abbott Laboratories, Inc. Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Abbott Laboratories, Inc. Main Business Overview
- 11.1.5 Abbott Laboratories, Inc. Latest Developments
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Information
- 11.2.2 Thermo Fisher Scientific Drug of Abuse Screening Product Offered
- 11.2.3 Thermo Fisher Scientific Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Thermo Fisher Scientific Main Business Overview
- 11.2.5 Thermo Fisher Scientific Latest Developments
- 11.3 LabCorp (Laboratory Corporation of America)
- 11.3.1 LabCorp (Laboratory Corporation of America) Company Information
- 11.3.2 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Product Offered
- 11.3.3 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 LabCorp (Laboratory Corporation of America) Main Business Overview
- 11.3.5 LabCorp (Laboratory Corporation of America) Latest Developments
- 11.4 Psychemedics Corporation
- 11.4.1 Psychemedics Corporation Company Information
- 11.4.2 Psychemedics Corporation Drug of Abuse Screening Product Offered
- 11.4.3 Psychemedics Corporation Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Psychemedics Corporation Main Business Overview
- 11.4.5 Psychemedics Corporation Latest Developments
- 11.5 Sonic Healthcare
- 11.5.1 Sonic Healthcare Company Information
- 11.5.2 Sonic Healthcare Drug of Abuse Screening Product Offered
- 11.5.3 Sonic Healthcare Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Sonic Healthcare Main Business Overview
- 11.5.5 Sonic Healthcare Latest Developments
- 11.6 Bio-Rad Laboratories
- 11.6.1 Bio-Rad Laboratories Company Information
- 11.6.2 Bio-Rad Laboratories Drug of Abuse Screening Product Offered
- 11.6.3 Bio-Rad Laboratories Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bio-Rad Laboratories Main Business Overview
- 11.6.5 Bio-Rad Laboratories Latest Developments
- 11.7 Quest Diagnostics
- 11.7.1 Quest Diagnostics Company Information
- 11.7.2 Quest Diagnostics Drug of Abuse Screening Product Offered
- 11.7.3 Quest Diagnostics Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Quest Diagnostics Main Business Overview
- 11.7.5 Quest Diagnostics Latest Developments
- 11.8 Randox Laboratories
- 11.8.1 Randox Laboratories Company Information
- 11.8.2 Randox Laboratories Drug of Abuse Screening Product Offered
- 11.8.3 Randox Laboratories Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Randox Laboratories Main Business Overview
- 11.8.5 Randox Laboratories Latest Developments
- 11.9 F. Hoffman-La Roche
- 11.9.1 F. Hoffman-La Roche Company Information
- 11.9.2 F. Hoffman-La Roche Drug of Abuse Screening Product Offered
- 11.9.3 F. Hoffman-La Roche Drug of Abuse Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 F. Hoffman-La Roche Main Business Overview
- 11.9.5 F. Hoffman-La Roche Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Drug of Abuse Screening. Industry analysis & Market Report on Drug of Abuse Screening is a syndicated market report, published as Global Drug of Abuse Screening Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Drug of Abuse Screening market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
